title: Infliximab and occult hepatitis B infection: to treat or not to treat?
authors.forename: Ashish
authors.initials: A
authors.lastname: Goel
authors.forename: C E
authors.initials: CE
authors.lastname: Eapen
authors.forename: Debashish
authors.initials: D
authors.lastname: Danda
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000453:epidemiology*; D005260:Female; D006509:Hepatitis B / Q000453:epidemiology*; D006515:Hepatitis B virus; D006801:Humans; D000069285:Infliximab; D008297:Male
chemical_list: D000911:Antibodies, Monoclonal; D000069285:Infliximab